Overcoming ex vivo cell therapy manufacturing challenges through an in vivo lentiviral platform: scalability, supply chain, and cogs
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI